To determine whether Vps18 deficiency promotes tumor development by enhancing EGFR signaling, we investigated whether expressing dominant negative EGFR (dnEGFR) could suppress the lung tumor-promoting phenotype caused by Vps18 loss. This evidence concerns the gene VPS18 and neoplasm.